Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing

Brian S. Decker, JM Barbarino, JF Peterson et al. · Clinical Pharmacology & Therapeutics · 2015 · 663 citations · Full text

Immunology, Pharmacotherapy, Immunotherapy +17

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

Nauras Shuker, Rachida Bouamar, Ron H. N. van Schaik et al. · American Journal of Transplantation · 2015 · 164 citations · Full text

Urology, Transplantation, Kidney Transplant +15

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles

William S. Oetting, David P. Schladt, W. Guan et al. · American Journal of Transplantation · 2015 · 114 citations · Full text

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Wiebke Albrecht, Franziska Kappenberg, Tim Brecklinghaus et al. · Archives of Toxicology · 2019 · 104 citations · Full text

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

Gemma D. Banham, Shaun Flint, Nicholas Torpey et al. · The Lancet · 2018 · 90 citations · Full text

Placebo-controlled Phase 2, Urology, Transplantation +7